PatientIQ

PatientIQ announced $30M in Series C financing on September 3, 2026. PatientIQ raised a $30 million Series C led by Hughes and Company to deepen its presence across existing specialties and health systems, expand its real-world evidence platform for medical device and life sciences companies, and build a direct-to-patient commerce experience.

Round details

The financing includes backing from Hughes and Company. The company did not publish a valuation with the announcement.

• Round: Series C
• Capital announced: $30M

How the company plans to use the capital

PatientIQ said the financing will support deepening its presence across existing specialties and health systems, expanding its real-world evidence platform for medical device and life sciences companies, and building a direct-to-patient commerce experience.

Why this matters for GTM teams

PatientIQ said it is trusted by more than 870 healthcare organizations and plans to expand its real-world evidence platform for medical device and life sciences companies.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: PatientIQ Series C announcement.